-+ 0.00%
-+ 0.00%
-+ 0.00%

BRAVEHEART BIO, - Q2 NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS WAS $18.60 MLN OR $2.51 PER SHARE

Reuters·09/08/2026 20:03:01

Please log in to view news